HASHEM EL-SERAG to Combined Modality Therapy
This is a "connection" page, showing publications HASHEM EL-SERAG has written about Combined Modality Therapy.
Connection Strength
0.285
-
Esophageal carcinoma. N Engl J Med. 2014 Dec 25; 371(26):2499-509.
Score: 0.090
-
Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology. 2008 May; 134(6):1752-63.
Score: 0.057
-
Human immunodeficiency virus-associated squamous cell cancer of the anus: epidemiology and outcomes in the highly active antiretroviral therapy era. J Clin Oncol. 2008 Jan 20; 26(3):474-9.
Score: 0.056
-
Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study. J Hepatol. 2006 Jan; 44(1):158-66.
Score: 0.048
-
Symptomatic reflux disease: the present, the past and the future. Gut. 2014 Jul; 63(7):1185-93.
Score: 0.021
-
Screening for hepatocellular carcinoma among veterans with hepatitis C on disease stage, treatment received, and survival. Clin Gastroenterol Hepatol. 2007 Apr; 5(4):508-12.
Score: 0.013